These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8837803)

  • 1. Patients with polycystic kidney disease would benefit from routine magnetic resonance angiographic screening for intracerebral aneurysms: a decision analysis.
    Butler WE; Barker FG; Crowell RM
    Neurosurgery; 1996 Mar; 38(3):506-15; discussion 515-6. PubMed ID: 8837803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of screening for asymptomatic, unruptured intracranial aneurysms. A mathematical model.
    Yoshimoto Y; Wakai S
    Stroke; 1999 Aug; 30(8):1621-7. PubMed ID: 10436111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR Angiography Screening and Surveillance for Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Cost-effectiveness Analysis.
    Malhotra A; Wu X; Matouk CC; Forman HP; Gandhi D; Sanelli P
    Radiology; 2019 May; 291(2):400-408. PubMed ID: 30777807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rupture of a previously documented small asymptomatic intracranial aneurysm in a patient with autosomal dominant polycystic kidney disease. Case report.
    Schievink WI; Prendergast V; Zabramski JM
    J Neurosurg; 1998 Sep; 89(3):479-82. PubMed ID: 9724126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive screening for intracranial aneurysms.
    Rinkel GJ; Ruigrok YM
    Int J Stroke; 2022 Jan; 17(1):30-36. PubMed ID: 34042530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for unruptured familial intracranial aneurysms. A decision analysis.
    Dippel DW; ter Berg JW; Habbema JD
    Acta Neurol Scand; 1992 Oct; 86(4):381-9. PubMed ID: 1455985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for intracranial aneurysms in autosomal dominant polycystic kidney disease is cost-effective.
    Flahault A; Trystram D; Nataf F; Fouchard M; Knebelmann B; Grünfeld JP; Joly D
    Kidney Int; 2018 Mar; 93(3):716-726. PubMed ID: 29061331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for aneurysms in risk groups: meaningful?].
    Struffert T; Reith W
    Radiologe; 2002 Nov; 42(11):880-4. PubMed ID: 12458440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of intracranial aneurysms and subarachnoid haemorrhage in patients with polycystic kidney disease.
    Gieteling EW; Rinkel GJ
    J Neurol; 2003 Apr; 250(4):418-23. PubMed ID: 12700905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance angiographic screening for asymptomatic intracranial aneurysms: the problem of false negatives: technical case report.
    Vanninen RL; Hernesniemi JA; Puranen MI; Ronkainen A
    Neurosurgery; 1996 Apr; 38(4):838-40; discussion 840-1. PubMed ID: 8692408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease.
    Schievink WI; Torres VE; Piepgras DG; Wiebers DO
    J Am Soc Nephrol; 1992 Jul; 3(1):88-95. PubMed ID: 1391712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult intracranial aneurysms in polycystic kidney disease. When is cerebral arteriography indicated?
    Levey AS; Pauker SG; Kassirer JP
    N Engl J Med; 1983 Apr; 308(17):986-94. PubMed ID: 6835317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for familial intracranial aneurysms: decision and cost-effectiveness analysis.
    Takao H; Nojo T; Ohtomo K
    Acad Radiol; 2008 Apr; 15(4):462-71. PubMed ID: 18342771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presymptomatic Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease.
    Sanchis IM; Shukoor S; Irazabal MV; Madsen CD; Chebib FT; Hogan MC; El-Zoghby Z; Harris PC; Huston J; Brown RD; Torres VE
    Clin J Am Soc Nephrol; 2019 Aug; 14(8):1151-1160. PubMed ID: 31362991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intracranial aneurysms in autosomal dominant polycystic kidney disease detected by MR angiography: screening and treatment].
    Iida H; Naito T; Hondo H; Demachi H; Aoki S
    Nihon Jinzo Gakkai Shi; 1998 Feb; 40(2):42-7. PubMed ID: 9567070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Comparison of Management Approaches.
    Wilkinson DA; Heung M; Deol A; Chaudhary N; Gemmete JJ; Thompson BG; Pandey AS
    Neurosurgery; 2019 Jun; 84(6):E352-E361. PubMed ID: 30060240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Unruptured brain aneurysms: when to screen and when to treat?].
    Fiehler J
    Rofo; 2012 Feb; 184(2):97-104. PubMed ID: 22234454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: prevalence, risk of rupture, and management. A systematic review.
    Cagnazzo F; Gambacciani C; Morganti R; Perrini P
    Acta Neurochir (Wien); 2017 May; 159(5):811-821. PubMed ID: 28283868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intracranial aneurysms and autosomal dominant polycystic kidney disease].
    van Dijk MA; Hogewind BL; Breuning MH; Rinkel GJ
    Ned Tijdschr Geneeskd; 2000 Jun; 144(26):1280-3. PubMed ID: 10908959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Factors Associated with the Risk of Intracranial Aneurysm Rupture in Autosomal Dominant Polycystic Kidney Disease.
    Lee CH; Ahn C; Ryu H; Kang HS; Jeong SK; Jung KH
    Cerebrovasc Dis; 2021; 50(3):339-346. PubMed ID: 33706308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.